Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2013
Date:5/7/2013

CARLSBAD, Calif., May 7, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today reported pro forma operating income of $4.5 million and pro forma net income of $1.2 million for the three months ended March 31, 2013 compared to a pro forma net operating loss of $16.2 million and a pro forma net loss of $21.7 million for the same period in 2012.  The significant improvement in the Company's financial results was driven primarily by milestone payments Isis earned in the first quarter, including a $25 million milestone payment from Genzyme and a $7.5 million milestone payment from GlaxoSmithKline (GSK).  In addition, Isis maintained its cash position by ending the first quarter of 2013 with approximately $372 million compared to approximately $374 million at December 31, 2012. On a GAAP basis, Isis reported income from operations of $1.6 million and a net loss of $1.7 million for the three months ended March 31, 2013 compared to a loss from operations of $18.5 million and a net loss of $24.0 million for the same period in 2012.

"The most significant event for Isis this quarter was the approval and launch of KYNAMRO™ in the United States to treat patients with homozygous familial hypercholesterolemia.  The approval of KYNAMRO is an important event for these patients who have a severe disease and who struggle daily to control their LDL-C levels.  Genzyme has commercially launched KYNAMRO and has physicians qualified under the REMS program.  KYNAMRO approval is also an important milestone for Isis and our antisense technology.  KYNAMRO is the first systemically delivered antisense drug to be sold commercially and is the culmination of many years of hard work and scientific achievements.  We are looking forward to updating you on KYNAMRO's commercial progress later in the year," said B. Lynne Parshall, chief operating officer of
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Perrigo Reports Record Revenue and Adjusted Earnings
2. Discovery Labs Reports First Quarter 2013 Financial Results
3. Endo Reports First Quarter Financial Results
4. Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
5. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
6. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
7. IRIDEX Reports 2013 First Quarter Results
8. Masimo Reports First Quarter 2013 Financial Results
9. Neurocrine Biosciences Reports First Quarter 2013 Results
10. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
11. Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)...  The National Association of Drug Diversion Investigators ... the real-time, pseudoephedrine (PSE) blocking system in Missouri. The ... (NPLEx), automatically blocks unlawful pseudoephedrine sales and helps ... make arrests. Data released by NPLEx shows electronic ... the sale of more than 19,030 boxes of medicine ...
(Date:8/20/2014)... , Aug. 20, 2014 PTC Therapeutics, Inc. (NASDAQ: ... two upcoming investor conferences: - FBR 1 st ... Boston on Wednesday, September 3 rd ... The Mandarin Oriental Boston on Thursday, September 4 th ... update at the Bank of America Merrill Lynch Global Healthcare ...
Breaking Medicine Technology:Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2PTC Therapeutics to Participate at Upcoming Investor Conferences 2
... CINCINNATI, Jan. 12, 2012   Prasco® Laboratories announced today ... (NASDAQ: SHPGY ) for the distribution ...   version of Carbatrol® (Carbamazepine) Extended-Release Capsules in 100 ... Carbamazepine Extended-Release Capsules are AB-rated, therapeutically equivalent and ...
...   Optimer Pharmaceuticals, Inc. (NASDAQ: ... Ph.D., Chief Operating Officer & Senior Vice President, ... other interests. (Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ... been a great experience building Optimer Pharmaceuticals and bringing ...
Cached Medicine Technology:Prasco® Launches Authorized Generic of Shire's Carbatrol® 2Prasco® Launches Authorized Generic of Shire's Carbatrol® 3Prasco® Launches Authorized Generic of Shire's Carbatrol® 4Chief Operating Officer Tessie M. Che Departing Company 2Chief Operating Officer Tessie M. Che Departing Company 3
(Date:8/20/2014)... Recently, UWDress.com, the distinguished wedding dress manufacturer and ... party dresses for girls . According to the company’s ... handmade by experienced specialists. Now, they are provided with ... company’s new items come in various styles: A-line scalloped ... long elegant backless gowns and so on. It is ...
(Date:8/20/2014)... An Elle Magazine online report dated August ... Looking Young at Every Age,” offers a set of recommendations ... . These recommendations are offered as a preventative skincare ... 25-45 and beyond. The first group of recommendations can be ... includes using sunscreen religiously, getting sufficient exercise and sleep, and ...
(Date:8/20/2014)... August 20, 2014 Today, Zane ... the publication of a new eBook, Affordable Care ... small business owners feel uncertain about how the ... and their bottom line. , The new eBook ... helps businesses navigate their upcoming health insurance decisions. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Ticket Down ... tickets in NYC. In just a week, the U.S. ... King Tennis Center. The event was originally founded in 1881 and ... Rafael Nadal was forced to withdrawal from the event because of ... women’s tournament and will return to New York City with hopes ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... experimental drug has saved a group of rhesus monkeys from ... that kills up to 90 percent of those it infects, ... lethal doses of Marburg virus, even when it was given ... 20 in the journal Science Translational Medicine . ...
Breaking Medicine News(10 mins):Health News:Cheap Birthday Party Dresses for Girls Now Available at UWDress.com 2Health News:Simon Ourian, Kim Kardashian’s Doctor, On Healthy Skin Suggestions for Every Age 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3
... fill gaps and offset rising employee-paid healthcare costs. , ... ... employers have completed their annual benefit enrollment period, Combined Insurance ... insurance benefits and coverage to identify potential gaps in coverage due ...
... , ... Cincinnati, OH (PRWEB) February ... an innovative solution to a pressing health care concern – ... medication therapy., , ,This concern was underscored in a recent ...
... Raw Materials CatalogST. LOUIS, Feb. 10 SAFC Supply ... the Sigma-Aldrich Group (Nasdaq: SIAL ) ... today announced that it has added 50 new Certified ... materials product line. Details of the new products ...
... rBGH milk from Yoplait Yogurt."SAN FRANCISCO, Feb. 9 ... watchdog of the breast cancer movement - today ... General Mills remove the cancer-linked synthetic growth hormone, ... of BCA,s 2008 "Think Before You Pink" campaign ...
... Publish Study Defining Mechanism,and Potential Treatment for Rett Syndrome, ... Clinical trial to test molecule in humans is being ... apply to other forms of autism - , BOSTON ... innovative research, clinical and family collaboration dedicated to radically ...
... Feb. 9 Ten health professional students pursuing ... and $2,000 scholarships from the National Hispanic Health ... Professional Student Scholarship Gala at the Sheraton Grand ... keynote speaker will be the Honorable Dean Florez, ...
Cached Medicine News:Health News:Leading Supplemental Insurer Recommends Insurance Review Following Annual Benefit Enrollment Period 2Health News:Leading Supplemental Insurer Recommends Insurance Review Following Annual Benefit Enrollment Period 3Health News:AdherenceRx Partners with Hummingbird Coaching To Increase Patient Medication Adherence 2Health News:AdherenceRx Partners with Hummingbird Coaching To Increase Patient Medication Adherence 3Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 2Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 3Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 4Health News:Breast Cancer Action Victorious in Yoplait 'Pinkwashing' Campaign 2Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 2Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 3Health News:NHHF Scholarship Program Targets Growing Demand for Diversity Among Health Care Professionals 2
Security and confidence assured with porous tape; integral deodorizing/venting filter....
Inquire...
Inquire...
Superior Skin Care...Convex FlexWear skin barrier is secure and provides extended weartime. Security and confidence assured with internal non-reflux valves and a drain valve that allows regulation of...
Medicine Products: